XML 48 R34.htm IDEA: XBRL DOCUMENT v2.4.1.9
Fair Value Measurements (Tables)
3 Months Ended
Mar. 31, 2015
Fair Value Disclosures [Abstract]  
Summary of assets and liabilities recorded at fair value
The tables below present information about our assets and liabilities that are regularly measured and carried at fair value and indicate the level within the fair value hierarchy of the valuation techniques we utilized to determine such fair value:
As of March 31, 2015 (In millions)
Total
 
Quoted Prices
in Active
Markets
(Level 1)
 
Significant Other
Observable Inputs
(Level 2)
 
Significant
Unobservable
Inputs
(Level 3)
Assets:
 
 
 
 
 
 
 
Cash equivalents
$
752.5

 
$

 
$
752.5

 
$

Marketable debt securities:
 
 
 
 
 
 
 
Corporate debt securities
991.0

 

 
991.0

 

Government securities
850.6

 

 
850.6

 

Mortgage and other asset backed securities
209.6

 

 
209.6

 

Marketable equity securities
6.2

 
6.2

 

 

Venture capital investments
12.1

 

 

 
12.1

Derivative contracts
168.2

 

 
168.2

 

Plan assets for deferred compensation
44.1

 

 
44.1

 

Total
$
3,034.3

 
$
6.2

 
$
3,016.0

 
$
12.1

Liabilities:
 
 
 
 
 
 
 
Derivative contracts
$
12.6

 
$

 
$
12.6

 
$

Contingent consideration obligations
461.8

 

 

 
461.8

Total
$
474.4

 
$

 
$
12.6

 
$
461.8


As of December 31, 2014 (In millions)
Total
 
Quoted Prices
in Active
Markets
(Level 1)
 
Significant
Other
Observable
Inputs
(Level 2)
 
Significant
Unobservable
Inputs
(Level 3)
Assets:
 
 
 
 
 
 
 
Cash equivalents
$
716.3

 
$

 
$
716.3

 
$

Marketable debt securities:
 
 
 
 
 
 
 
Corporate debt securities
1,063.0

 

 
1,063.0

 

Government securities
849.8

 

 
849.8

 

Mortgage and other asset backed securities
198.3

 

 
198.3

 

Marketable equity securities
6.9

 
6.9

 

 

Venture capital investments
14.5

 

 

 
14.5

Derivative contracts
72.7

 

 
72.7

 

Plan assets for deferred compensation
36.9

 

 
36.9

 

Total
$
2,958.4

 
$
6.9

 
$
2,937.0

 
$
14.5

Liabilities:
 
 
 
 
 
 
 
Derivative contracts
$
5.4

 
$

 
$
5.4

 
$

Contingent consideration obligations
215.5

 

 

 
215.5

Total
$
220.9

 
$

 
$
5.4

 
$
215.5

Fair value of venture capital investments
The following table provides a roll forward of the fair value of our venture capital investments, which includes Level 3 measurements:
 
For the Three Months
Ended March 31,
(In millions)
2015
 
2014
Fair value, beginning of period
$
14.5

 
$
21.9

Unrealized gains included in earnings

 
2.9

Unrealized losses included in earnings
(2.4
)
 
(1.2
)
Fair value, end of period
$
12.1

 
$
23.6

Summary of fair and carrying value of debt instruments
The fair and carrying values of our debt instruments, which are Level 2 liabilities, are summarized as follows:
 
As of March 31, 2015
 
As of December 31, 2014
(In millions)
Fair
Value
 
Carrying
Value
 
Fair
Value
 
Carrying
Value
Notes payable to Fumedica
$
12.9

 
$
12.1

 
$
12.6

 
$
11.7

6.875% Senior Notes due March 1, 2018
633.9

 
571.8

 
634.6

 
573.5

Total
$
646.8

 
$
583.9

 
$
647.2

 
$
585.2

Fair value of contingent consideration obligations
The following table provides a roll forward of the fair values of our contingent consideration obligations which includes Level 3 measurements:
 
For the Three Months
Ended March 31,
(In millions)
2015
 
2014
Fair value, beginning of period
$
215.5

 
$
280.9

Additions
238.5

 

Changes in fair value
7.8

 
(0.8
)
Payments

 
(5.0
)
Fair value, end of period
$
461.8

 
$
275.1